Thursday, February 05, 2015 5:14:33 PM
4:20 PM ET 2/5/15 | Briefing.com
Reports Q4 (Dec) earnings of $2.35 per share, $0.02 worse than the Capital IQ Consensus Estimate of $2.37; revenues rose 1.2% year/year to $600.6 mln vs the $600.6 mln consensus.
Co issues in-line guidance for FY15, sees EPS of $6.71-7.71 vs. $7.57 Capital IQ Consensus Estimate; sees FY15 revs of $2.314-2.464 bln vs. $2.4 bln Capital IQ Consensus Estimate.
Sees FY15 Free Cash Flow of $205-245 mln
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM